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Abstract
Here, we describe the case of a 62-year old woman who required aortic and
mitral valve replacement plus coronary artery bypass grafting. Transoesophageal
echocardiogram revealed stenosis of the aortic valve (Ao valve area, 0.9 cm(2);
PG, 45 mmHg; MG, 25 mmHg) and a diseased calcified mitral valve with stenosis
and regurgitation (mitral valve area, 1.1 cm(2); MG, 10 mmHg; RV, 25 ml; ERO, 12
mm(2)). The mitral annulus calcifications were very deep into the left atrium and
the left ventricle muscle, around the full annulus circumference. We decided to
avoid complete deep mitral annulus decalcification. The left atrium was surgically
exposed, and we deployed a 26-mm Edwards SAPIEN XT endovalve through
the left atriotomy. To prevent paravalvular leakage, we then used a pericardial
patch to close the gap between the endovalve and the calcified mitral annulus.
The postoperative echocardiogram showed perfect anchoring of the endovalve
in the mitral annulus without any paravalvular leakage.
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Abstract
Here, we describe the case of a 62-year old woman who required aortic and mitral valve replacement plus coronary artery bypass grafting.
Transoesophageal echocardiogram revealed stenosis of the aortic valve (Ao valve area, 0.9 cm2; PG, 45 mmHg; MG, 25 mmHg) and a dis-
eased calciﬁed mitral valve with stenosis and regurgitation (mitral valve area, 1.1 cm2; MG, 10 mmHg; RV, 25 ml; ERO, 12 mm2). The mitral
annulus calciﬁcations were very deep into the left atrium and the left ventricle muscle, around the full annulus circumference. We decided
to avoid complete deep mitral annulus decalciﬁcation. The left atrium was surgically exposed, and we deployed a 26-mm Edwards SAPIEN
XT endovalve through the left atriotomy. To prevent paravalvular leakage, we then used a pericardial patch to close the gap between the
endovalve and the calciﬁed mitral annulus. The postoperative echocardiogram showed perfect anchoring of the endovalve in the mitral
annulus without any paravalvular leakage.
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CASE REPORT
A 62-year old woman was admitted to hospital for heart failure.
Transoesophageal echocardiogram revealed aortic valve stenosis
(Ao valve area, 0.9 cm2; PG, 45 mmHg; MG, 25 mmHg) and a dis-
eased calciﬁed mitral valve with stenosis and regurgitation (mitral
valve area, 1.1 cm2; MG, 10 mmHg; RV, 25 ml; ERO, 12 mm2). The
preoperative coronary angiogram showed double-vessel disease.
The calculated EuroSCORE II was 4.08. Her medical history
included chronic lymphocytic leukaemia in 1999 with recurrence
in 2004, 2005 and 2007, requiring multiple courses of chemother-
apy. She also had renal cancer that was treated with right nephrec-
tomy in 2006, followed by end-stage renal insufﬁciency and
deﬁnitive dialysis.
We proposed surgical aortic valve replacement, mitral valve re-
placement and double coronary bypass grafting. The procedure
started with cardiopulmonary bypass (CPB) insertion and cardio-
plegia. Then, we decalciﬁed the aortic valve ﬁrst, even though the
aortic and mitral calciﬁcations were fused. Opening the left atrium
and exposing the mitral valve revealed heavy mitral annulus calci-
ﬁcations, which were very deep into the left atrium and the left
ventricle muscle, around the full annulus circumference. We
decided to avoid complete deep mitral annulus decalciﬁcation
(Fig. 1A). Using the transapical Ascendra system (Edwards
Lifesciences, Inc., Irvine, CA, USA), we inserted a 26-mm Edwards
SAPIEN XT valve (Edwards Lifesciences, Inc.) through the left
atriotomy under visual control (Fig. 1B), without using guide wire
or ﬂuoroscopy.
The balloon was inﬂated into the calciﬁed annulus. After deﬂation,
we tested the anchoring of the endovalve into the mitral annulus.
The valve diameter perfectly ﬁt the mitral annulus diameter, and it
was impossible to pull back the stented valve with our forceps
(Fig. 1C). However, the water test revealed paravalvular leakage
around the stented valve. The annulus was not perfectly circular and
was heavily calciﬁed, inducing some degree of non-apposition of
the endovalve around the annulus. To prevent paravalvular leakage,
we closed the gap between the endovalve and the calciﬁed annulus
using a ring of bovine pericardium, with one side sutured on the
stent and the other side on the atrial tissue over the annulus calciﬁ-
cation (Fig. 2A). We used a running suture of Prolene 4.0 to close the
gap. The water test then showed no leakage (Fig. 2B).
The atrium was closed using a running suture of Prolene 3.0.
PERIMOUNT Magna (21 mm; Edwards Lifesciences, Inc.) was
implanted in the aortic position. A double venous bypass was per-
formed on the right and ﬁrst marginal coronary arteries. The CPB
weaning was performed easily. Postoperative echocardiography
showed a good position of the endovalve in the mitral annulus,
with a 2.0-cm2 valve area and a 3-mmHg mean gradient without
paravalvular leakage (Fig. 2C).
DISCUSSION
Mitral valve surgery in the presence of extensive annular calciﬁca-
tion remains a surgical challenge. In 1987, Cammack et al. [1] re-
ferred to mitral annulus calciﬁcation as ‘the bar of death’; at that
time, the mortality after such surgery was 30%. To approach the dif-
ﬁcult problem of mitral valve surgery after decalciﬁcation, several
techniques have been described, with a number of severe compli-
cations, including left ventricular rupture, haemorrhagic
© The Author 2013. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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complications, atrioseptal defect and atrioventricular ﬁstula.
Improved management of these complications during this complex
surgery has led to decreased mortality. Recently, Feindel et al. [2]
reported an operative mortality of 9.3%. The ﬁve deaths in that
study included two due to severe coagulopathy, one to low cardiac
output, one to sepsis and multiorgan failure and one to myocardial
Figure 1: (A) Intraoperative view of the heavily calciﬁed mitral annulus. (B) Positioning of the Edwards SAPIEN valve under visual inspection without any guiding wire
or ﬂuoroscopy. (C) Deployment of the Edwards SAPIEN valve with careful positioning into the calciﬁed mitral annulus.
Figure 2: (A) The custom-made bovine pericardium ring used to close the gap between the endovalve and the calciﬁed mitral annulus to avoid paravalvular leakage.
(B) Final outcome of using the sutured pericardial patch to close the paravalvular leakage area around the endovalve, resulting in a perfect water test.
(C) Postoperative echocardiography shows the perfect positioning of the mitral Edwards valve without any paravalvular leakage. The chest X-ray shows both the aortic
and mitral bioprosthetic valves.
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infarction complicated by posterior interventricular septum rupture
related to occlusion of a diseased right coronary artery.
El Asmar et al. [3] described a technique of mitral valve repair to
avoid the risks associated with mitral valve replacement in a se-
verely calciﬁed mitral annulus. They performed mitral valve repair
by en bloc resection of the annular calcium deposits, and annular
reconstruction was performed using pledgeted-supported
sutures, with good results. However, this technique is limited by
the requirements for a repairable valve and non-extensive calciﬁ-
cation, as radical decalciﬁcation leaves tissue that is of poor quality
for holding sutures and atrioventricular ﬁstula.
Small case series have recently described the successful off-
label use of transcatheter aortic valve implantation (TAVI) in
patients with degenerated bioprosthetic valves in the mitral pos-
ition. This technique was ﬁrst demonstrated in seven sheep
models by Kempfert et al. [4]; they implanted a 26-mm Physio
ring, then positioned an Edwards SAPIEN valve within the annu-
loplasty ring under ﬂuoroscopic guidance. In 2010, Webb et al.
[5] published a study involving valve-in-valve implantations in
seven mitral bioprostheses. They reported successful Edwards
SAPIEN valve implantation, with immediate restoration of satis-
factory valve function in all patients. No patient had more than
mild regurgitation after implantation, and no patient died during
the procedure. Thirty-day mortality was 4.2%. Each of the above-
described studies used a valve-in-valve technique, with the
endovalve seated in an artiﬁcial rigid structure (Physio ring or
bioprosthesis). In the present case report, we describe a totally
new concept, in which the endovalve was placed into a native
calciﬁed mitral annulus. We further used a ring pericardial patch
to prevent paravalvular leakage between the endovalve and the
native annulus. To our knowledge, this is also the ﬁrst report of
Edwards SAPIEN valve implantation using the Ascendra system
through a left atrium access.
The described technique was a bailout procedure to reduce the
operative mortality associated with complete mitral annulus
decalciﬁcation during a long procedure requiring bi-valve re-
placement and double bypass grafting. In such a case, the use of a
balloon-expandable valve under visual control must be consid-
ered, as this technique decreases the operative time and the po-
tential injuries of full mitral decalciﬁcation. The present case
shows the feasibility of using TAVI during open surgery, with easy
valve positioning and deployment without any guiding system or
ﬂuoroscopy. The visual inspection and slow inﬂation of the
balloon provide accurate endovalve positioning in the native calci-
ﬁed mitral annulus.
In conclusion, we report that the use of a sutureless valve, such
as an Edwards SAPIEN valve, is a promising method for mitral
valve replacement in complex cases involving bar calciﬁcation of
the mitral annulus.
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